What's in Nourhan M.Aly's pipeline?

Nourhan M.Aly has 11 drugs in our index: 4 marketed, 0 filed, 1 in Phase 3, 6 in Phase 2, 0 in Phase 1.

Which companies overlap with Nourhan M.Aly's portfolio?

Top competitors by shared drug class: Wake Forest University Health Sciences, Medical University of Vienna, University Health Network, Toronto, Vanderbilt University Medical Center, American University of Beirut Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nourhan-m-aly.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Nourhan M.Aly — Portfolio Competitive Intelligence Brief

Nourhan M.Aly pipeline: 4 marketed, 0 filed, 1 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 1 Phase 3 6 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Hypertonic Dextrose Solution	Hypertonic Dextrose Solution	marketed
MTA pulp dressing material	MTA pulp dressing material	marketed	Dental restorative material / Endodontic cement		Dentistry / Endodontics
Topical Benzocaine 20%	Topical Benzocaine 20%	marketed	Local anesthetic	Voltage-gated sodium channels	Anesthesia / Pain Management
Duraphat	Duraphat	marketed			Other
Sublingual Dexmedetomidine	Sublingual Dexmedetomidine	phase 3	Alpha-2 adrenergic agonist	Alpha-2 adrenergic receptor	Anesthesiology

Therapeutic area mix

Other · 2
Anesthesia / Pain Management · 1
Anesthesiology · 1
Dentistry / Endodontics · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Wake Forest University Health Sciences · 2 shared drug classes
Medical University of Vienna · 2 shared drug classes
University Health Network, Toronto · 2 shared drug classes
Vanderbilt University Medical Center · 2 shared drug classes
American University of Beirut Medical Center · 1 shared drug class
Atlantic Health System · 1 shared drug class
Ain Shams University · 1 shared drug class
Aligarh Muslim University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nourhan M.Aly:

Cite this brief

Drug Landscape (2026). Nourhan M.Aly — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nourhan-m-aly. Accessed 2026-05-16.